¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Natural product research."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® VDRL(venereal disease research laboratory) ÇÑ±Û ¼ºº´ ¿¬±¸½ÇÇè½Ç
¼³¸í   
  ¸Åµ¶±ÕÀÇ reagin¿¡ ´ëÇÑ Ç×ü. ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ¿Í Ä¡·áÈ¿°ú ÆÇÁ¤¿¡µµ »ç¿ëµÈ´Ù. ¸Åµ¶¿Ü¿¡µµ Àü½Å¼ºÈ«¹Ý¼º³¶Ã¢, ·ù¸¶Æ¼½º°üÀý¿° µî¿¡¼­µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
¿µ¹® blood product ÇÑ±Û Ç÷¾×Á¦Á¦
¼³¸í   
  1. »ç¶÷ÀÇ Ç÷¾×À» ¼ººÐº°·Î ºÐ¸®ÇÏ¿©, ±×°ÍÀ» ¿ø·á·Î Á¦Á¶ÇÑ ÀǾàǰ. ¾Ç¼º Á¾¾ç µûÀ§¿¡ ¼öÇ÷Çϴ ÀûÇ÷±¸, ¹éÇ÷º´-ÀÚ»ö¹Ýº´ÀÇ ÃâÇ÷À» ¸Ü°ÔÇϴ Ç÷¼ÒÆÇ, È­»óÀÇ Ä¡·á¿¡ ¾²´Â Ç÷Àå, »êÈÄ ÃâÇ÷À» ¸Ü°Ô Çϴ ¼¶À¯¼Ò¿ø µûÀ§°¡ ÀÖ´Ù. 2. »ç¶÷ÀÇ Ç÷¾×ÇüÀ» °Ë»çÇϴµ¥ ¾²´Â ¾à.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • research
    ¿¬±¸
  • research design
    ¿¬±¸°èȹ
  • research diagnostic criteria
    ¿¬±¸Áø´Ü±âÁØ
  • venereal disease research laboratory test
    ¸Åµ¶Ç÷û°Ë»ç, VDRL°Ë»ç
  • assimilation product
    µ¿È­»ý¼º¹°
  • biological product
    »ý¹°ÇÐÀûÁ¦Á¦
  • blood product
    Ç÷¾×Á¦Á¦
  • degradation product
    ºÐÇØ»ê¹°
  • decay product
    ºØ±«»ê¹°
  • end product
    ÃÖÁ¾»ê¹°
  • fibrin degradation product
    ¼¶À¯¼ÒºÐÇØ»ê¹°, ÇǺ기ºÐÇØ»ê¹°
  • intermediate product
    Áß°£»ê¹°
  • leukocyte-depleted blood product
    ¹éÇ÷±¸Á¦°ÅÇ÷¾×Á¦Á¦
  • marine product
    ÇØ»ê¹°
  • product
    1. »ê¹° 2. »ý¼º¹°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • natural infection
    ÀÚ¿¬°¨¿°
  • research
    ¿¬±¸
  • diagnostic research
    Áø´Ü¿¬±¸
  • product
    »ý¼º¹°, »ê¹°
  • blood product
    Ç÷¾×Á¦Á¦
  • end product
    ÃÖÁ¾»ê¹°
  • fibrinogen degradation products product
    ¼¶À¯¼ÒºÐÇØ»ê¹°
  • fibrinogen degradation products product
    ¼¶À¯¼Ò¿øºÐÇØ»ê¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • research diagnostic criteria
    ¿¬±¸Áø´Ü±âÁØ
  • research design
    ¿¬±¸°èȹ
  • operational research
    ÀÛÀü¿¬±¸
  • research
    ¿¬±¸
  • venereal disease research laboratory test
    ¸Åµ¶Ç÷û°Ë»ç
  • assimilation product
    µ¿È­»ý»ê¹°
  • biological product
    »ý¹°ÇÐÀûÁ¦Á¦
  • blood product
    Ç÷¾×Á¦Á¦
  • pearson¡¯s product moment correlation
    ÇǾ»ó°ü°è¼ö
  • decay product
    ºØ±«»ê¹°
  • degradation product
    ºÐÇØ»ê¹°
  • end product
    ÃÖÁ¾»ê¹°
  • fibrin degradation product
    ¼¶À¯¼ÒºÐÇØ»ê¹°
  • intermediate product
    Áß°£»ê¹°, Áß°£´ë»ç¹°
  • leukocyte-depleted blood product
    ¹éÇ÷±¸Á¦°ÅÇ÷¾×Á¦Á¦
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • addition product
    ºÎ°¡»ý¼º¹°(¡­ßæà÷Úª).
  • product costing
    Á¦Ç°°¡°Ý»êÁ¤
  • product of metabolism
    ´ë»ç»ê¹°(ÓÛÞóß§Úª).
  • Lipid Research Clinic
    ÁöÁú¿¬±¸Áø·á¼Ò
  • NK cell [=natural killer cell]
    ÀÚ¿¬»ì»ó¼¼Æ÷
  • RDC, see Research Diagnostic Criteria
    ¿¬±¸Áø´Ü±âÁØ, ¿¬±¸¿ë Áø´Ü±âÁØ
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • VDRL test= venereal disease research laboratory test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • antibody, natural
    ÀÚ¿¬Ç×ü
  • infection, natural
    ÀÚ¿¬°¨¿°
  • persistence of natural atresia (imporferate duodenum)
    Æó¼â»óÅÂÁ¸¼Ó (½ÊÀÌÁöÀ帷ÈûÁõ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • research diagnostic criteria(RDC)
    ¿¬±¸Áø´Ü±âÁØ
  • venereal disease research laboratory test =VDRL test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • venereal disease research laboratory test =VDRL test
    ¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
  • addition product
    ºÎ°¡»ý¼º¹°(¡­ßæà÷Úª).
  • assimilation product
    µ¿È­»ý»ê¹°.
  • biological product
    »ý¹°ÇÐÀû Á¦Á¦(¡­ð²ð¥).
  • blood product
    Ç÷¾×Á¦Á¦.
  • by-product
    ºÎ»ê¹°.
  • decay product
    ºØ±«»ý¼º
  • degradation product
    ºÐÇØ»ê¹°(ÝÂú°ß§Úª)
  • distortion product otoacoustic emission
    º¯Á¶ÀÌÀ½Çâ¹Ý»ç
  • end product
    ÃÖÁ¾»ê¹°.»ýÈ­Á¾»ê¹°.
  • fibrin degradation product
  • intermediate product
    Áß°£»ý¼º¹°(¡­ßæà÷Úª), Áß°£»ê¹°, Áß°£´ë»ç¹°.
  • ionic product
    ÀÌ¿ÂÀû(¡­îÝ), À̿»깰.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Natural parthenogenesis
    ÀÚ¿¬Ã³³à»ý½Ä
    [¿¾ ¿ë¾î] ÀÚ¿¬Ã³³à»ý½Ä
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • excretory-secretory product
    ºÐºñ¹è¼³¹°
  • natural emerging method
    ÀÚ¿¬À¯Ãâ¹ý
  • natural host
    ÀÚ¿¬°¨¿°¼÷ÁÖ
  • natural resistance
    ¼±ÃµÀúÇ×
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • natural abundance
    ÀÚ¿¬ Á¸ÀçdzºÎ(í»æÔðíî¤ù¥Ý£)
  • natural antibody
    ÀÚ¿¬Ç×ü(í»æÔù÷ô÷)
  • natural auxin
    ÀÚ¿¬(í»æÔ) ¿Á½Å
  • natural immunity
    ÀÚ¿¬¸é¿ª(í»æÔØóæ¹)
  • natural immunization
    ÀÚ¿¬Á¢Á¾(í»æÔïÈðú)
  • natural killer cell
    ÀÚ¿¬ »ì¼¼Æ÷(í»æÔß¯á¬øà)
  • advanced glycosylation end product
    ÁøÇà ´çÈ­Á¾»ê¹°(òäú¼ÓØûùðûß§Úª)
  • Amadori product
    ¾Æ¸¶µµ¸® »ý¼º¹°(ßæà÷Úª)
  • by-product
    ºÎ»ê¹°(Üùß§Úª)
  • end product
    Á¾»ê¹°(ðûß§Úª)
  • end-product inhibition
    Á¾»ê¹° ÀúÇØ (ðûß§ÚªîÁúª)
  • end product repression
    Á¾»ê¹° ¾ïÁ¦ (ðûß§Úªåäð¤)
  • gene product
    À¯ÀüÀÚ(ë¶îîí­) »ê¹°
  • product
    »ê¹°(ß§Úª)
  • product inhibition
    »ê¹°ÀúÇØ(ß§ÚªîÁúª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • natural radioactivity
    õ¿¬¹æ»ç´É
  • dairy product
    ³«µ¿»ê¹°
  • product
    »ê¹°, »ý¼º¹°
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FDP fibrin degradation product; fibrinogen degradation product; flexor digitorum profundus; frontodextra...
NK cell Natural Killer cell
CNL cardiolipin natural lecithin; chronic neutrophilic leukemia
DND died a natural death
e base of natural logarithms, approximately 2.7182818285; egg transfer; ejection; electric charge; ele...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BDP break down product
CPSC Consumer Product Safety Commission
DPOAE Distorsion product otoacoustic emissions
DP Distortion Product
DPE Distortion Product Emission
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • JrId: 30319
    JournalTitle: Natural product research.
    MedAbbr: Nat Prod Res
    ISSN: 1478-6419
    ESSN:
    IsoAbbr: Nat. Prod. Res.
    NlmId: 101167924
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • natural product

    natural purification (ÀÚÁ¤ ÀÛ¿ë

    µ¿ÀǾî=self-
  • clinical research
    ÀÓ»ó ¿¬±¸
  • pain research laboratory
    µ¿Åë ¿¬±¸¼Ò
  • preclinical research
    ÀÓ»ó Àü ¿¬±¸
  • research
    ¿¬±¸, Á¶»ç
  • The National Institute of Dental Research
    ±¹¸³ Ä¡ÀÇÇÐ ¿¬±¸¼Ò
  • VDRL : Venereal Disease Research LaboratoryÀÇ ¾àÀÚ. ¸Åµ¶±ÕÀÇ Reagin¿¡ ´ëÇÑ Ç×ü·Î, ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ°¡ Ä¡·á È¿°ú ÆÇÁ¤¿¡ »ç¿ëµÈ´Ù. ¸Åµ¶ ¿Ü¿¡µµ Àü½Å¼º È«¹Ý¼º ³¶Ã¢(SLE), ·ù¸¶ÅäÀÌµå °üÀý¿° µî¿¡¼­µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
    VDRL ¸é»ó ¹ÝÀÀ
  • biological product
    »ý¹°ÇÐÀû Á¦Á¦
  • blood product
    Ç÷¾× Á¦Á¦
  • by-product
    ºÎ»ê¹°, ºÎ»ý¹°
    Áֻ깰À» »ý»êÇÏ´Â °úÁ¤¿¡¼­ »ý±â´Â ÀÌÂ÷Àû »ê¹°.
  • degradation product
    ºÐÇØ »ê¹°
  • distortion product otoacoustic emission
    º¯Á¶ ÀÌÀ½Ç⠹ݻç
  • inflammatory by-product
    ¿°Áõ ºÎ»ê¹°
  • ionic product
    ÀÌ¿ÂÀû, À̿ »ê¹°
  • metabolic waste product
    ´ë»ç ³ëÆó¹°, ´ë»ç »ê¹°
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
activation product <radiobiology> The unstable nucleus formed when activation occurs. (See activation above.)
(09 Oct 1997)
by-product <chemistry> A product of a chemical reaction or industrial process which is different from the desired product.
(20 Mar 1998)
by-product material Radioactive material produced by nuclear fission or by neutron irradiation in a nuclear reactor or similar device.
(05 Mar 2000)
gene product The biochemical material, either RNA or protein, resulting from expression of a gene. The amount of gene product is used to measure how active a gene is, abnormal amounts can be correlated with disease-causing alleles.
(09 Oct 1997)
Venereal Disease Research Laboratory <microbiology> A blood test used to diagnose syphilis.
Read as nonreactive or negative if you do not have syphilis. The Venereal Disease Research Laboratory can also be positive is cases of leprosy, malaria, mononucleosis, lupus, hepatitis A and pregnancy.
Positive Venereal Disease Research Laboratory tests are usually followed up by a more specific test (FTA antibodies).
(12 Jan 1998)
Medical Research Council <organisation> A UK Government funded body to promote the balanced development of medical and related biological research in the United Kingdom.
It organises national clinical trials for the assessment of new treatment protocols for leukaemia and some of the related diseases.
(05 Jan 1998)
research Careful, a diligent search, a close searching, studious inquiry or examination.
(18 Nov 1997)
research, controlled The first controlled clinical research was probably done in 1875 by the british naval surgeon james lind who, on board the hms salisbury, gave sailors with scurvy either oranges or lemons or cider or vinegar or nutmeg (or another treatment) and after just six days discovered that the citrus-consuming sailors had recovered from scury, until then the scourge of extended sea voyages, while the sailors who had been given the other treatments remained uncured.
(12 Dec 1998)
research design A plan for collecting and utilizing data so that desired information can be obtained with sufficient precision or so that an hypothesis can be tested properly.
(12 Dec 1998)
research personnel Those individuals engaged in research.
(12 Dec 1998)
research support Financial support of research activities.
(12 Dec 1998)
peer review, research The evaluation by experts of the quality and pertinence of research or research proposals of other experts in the same field. Peer review is used by editors in deciding which submissions warrant publication, by granting agencies to determine which proposals should be funded, and by academic institutions in tenure decisions.
(12 Dec 1998)
cleavage product A substance resulting from the splitting of a molecule into two or more simpler molecules.
(05 Mar 2000)
clinical nursing research Research carried out by nurses in the clinical setting and designed to provide information that will help improve patient care. Other professional staff may also participate in the research.
(12 Dec 1998)
clinical research trials Evaluating the safety and effectiveness of medications or medical devices by monitoring their effects on large groups of people. Clinical medical trials sponsored by the U. S. Government are listed on a web site of the National Institutes of Health (NIH). The NIH Clinical Centre intends to make details of current clinical research studies for various diseases available over the Internet to increase opportunities for patients and physicians to participate in clinical investigations.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • research
    ¿¬±¸
  • listener research
    Àαâ ÇÁ·ÎÁ¶»ç
  • market research
    (Á¦Ç°À» ¸ÅÃâÇϱâ ÀüÀÇ) ½ÃÀå Á¶»ç
  • market research
    ½ÃÀå Á¶»ç (¾î¶² »óǰÀÇ ¼ö¿ä¸¦ À§ÇÑ »çÀü Á¶»ç)
  • marketing research
    ½ÃÀå Á¶»ç;½ÃÀå ºÐ¼®
  • motivational research
    µ¿±â Á¶»ç
  • operations research
    ±â¾÷ °æ¿µ»óÀÇ °úÇÐÀû Á¶»ç ¿¬±¸;ÀÛÀü ¿¬±¸
  • research
    (Çмú)¿¬±¸;°úÇÐÀû ޱ¸;ÇмúÁ¶»ç;(½ÅÁßÇÑ)¼ö»ö;ޱ¸;Á¶»ç;¿¬±¸ ´É·Â;¿¬±¸½É;¿¬±¸ÇÏ´Ù;Á¶»çÇÏ´Ù;~able
  • research and development
    ¿¬±¸¿Í °³¹ß
  • research laboratory(institute)
    ¿¬±¸¼Ò
  • research library
    ¿¬±¸ µµ¼­°ü ´Â
  • research paper
    ¿¬±¸ ³í¹®;(ÇлýÀÇ)Çб⸻ ¸®Æ÷Æ®
  • research professor
    ¿¬±¸ ±³¼ö(´ëÇÐ µî¿¡¼­ ÀÚÀ¯·ÎÀÌ ¿¬±¸¿¡ ¸ôµÎÇÒ ¼ö ÀÖ´Â ±³¼ö)
  • research reactor
    ¿¬±¸¿ë ¿øÀÚ·Î
  • research submersible
    ½ÉÇØ Àá¼ö Á¶»ç¼±
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á